Growing community of inventors

Basel, Switzerland

Marta Cosenza

Average Co-Inventor Count = 3.00

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 15

Marta Cosenza ↔ Stefanie Urlinger (3 patents)Marta Cosenza ↔ Christoph Heusser (3 patents)Marta Cosenza ↔ Julia Neugebauer (3 patents)Marta Cosenza ↔ Eveline Schaadt (3 patents)Marta Cosenza ↔ Christoph Stark (3 patents)Marta Cosenza ↔ Maximilian Woisetschlaeger (2 patents)Marta Cosenza ↔ Maximilian Woisetschlaeger (1 patent)Marta Cosenza ↔ Christoph Stark (1 patent)Marta Cosenza ↔ Christoph Stark (0 patent)Marta CosenzaMarta Cosenza (6 patents)Stefanie UrlingerStefanie Urlinger (16 patents)Christoph HeusserChristoph Heusser (16 patents)Julia NeugebauerJulia Neugebauer (13 patents)Eveline SchaadtEveline Schaadt (8 patents)Christoph StarkChristoph Stark (3 patents)Maximilian WoisetschlaegerMaximilian Woisetschlaeger (5 patents)Maximilian WoisetschlaegerMaximilian Woisetschlaeger (2 patents)Christoph StarkChristoph Stark (1 patent)Christoph StarkChristoph Stark (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Novartis Ag (5 from 3,923 patents)

2. Novartis Pharma Ag (1 from 29 patents)


6 patents:

1. 12054555 - Anti-BAFFR antibody formulations and methods of use thereof

2. 10899841 - Anti-BAFFR antibody formulations and methods of use thereof

3. 10689451 - Anti-BAFFR antibody therapeutic formulations

4. 9751951 - Methods of treatment by administering an anti-BAFFR antibody therapeutic formulation

5. 9458240 - Anti-BAFFR antibody formulations

6. 9216219 - Anti-BAFFR antibody formulation

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/26/2025
Loading…